HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+9.36%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$3.04B
AUM Growth
+$218M
(+7.7%)
Cap. Flow
+$88M
Cap. Flow
% of AUM
2.89%
Top 10 Holdings %
Top 10 Hldgs %
52.11%
Holding
62
New
17
Increased
15
Reduced
10
Closed
16
Top Buys
| 1 |
HCA Healthcare
HCA
|
$123M |
| 2 |
Thermo Fisher Scientific
TMO
|
$114M |
| 3 |
Quest Diagnostics
DGX
|
$110M |
| 4 |
Elevance Health
ELV
|
$96.7M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$60.4M |
Top Sells
| 1 |
Dentsply Sirona
XRAY
|
$145M |
| 2 |
Pediatrix Medical
MD
|
$76.9M |
| 3 |
Agilent Technologies
A
|
$70.5M |
| 4 |
AbbVie
ABBV
|
$54.3M |
| 5 |
IQVIA
IQV
|
$54.1M |
Sector Composition
| 1 | Healthcare | 90.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Universal Health Services
UHS
$11.6B
| $48.8M | 1.55% |
+437,620
| New | +$48.8M |
|
|
XENT
27
DELISTED
Intersect ENT, Inc
XENT
| $47.5M | 1.51% |
1,268,850
+804,000
| +173% | +$30.1M |
|
|
CERN
28
DELISTED
Cerner Corp
CERN
| $45.6M | 1.45% |
+761,940
| New | +$45.6M |
|
29
Dynavax Technologies
DVAX
$1.19B
| $38.6M | 1.23% |
2,531,107
+1,212,495
| +92% | +$18.5M |
|
|
MDCO
30
DELISTED
Medicines Co
MDCO
| $36.8M | 1.17% |
1,003,948
+18,726
| +2% | +$687K |
|
31
Centene
CNC
$14.8B
| $36.1M | 1.15% |
+586,360
| New | +$36.1M |
|
32
Exact Sciences
EXAS
$9.33B
| $34.2M | 1.09% |
+572,240
| New | +$34.2M |
|
33
Bristol-Myers Squibb
BMY
$96.7B
| $27M | 0.86% |
488,750
-112,330
| -19% | -$6.22M |
|
34
Boston Scientific
BSX
$159B
| $23.1M | 0.74% |
707,860
+134,380
| +23% | +$4.39M |
|
35
Stryker
SYK
$149B
| $17.9M | 0.57% |
+106,290
| New | +$17.9M |
|
|
CVRS
36
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $16.5M | 0.52% |
19,981,655
| – | – |
|
37
Hologic
HOLX
$14.7B
| $13.8M | 0.44% |
+345,900
| New | +$13.8M |
|
|
AGN
38
DELISTED
Allergan plc
AGN
| $11M | 0.35% |
66,210
-225,310
| -77% | -$37.6M |
|
39
Amgen
AMGN
$153B
| $9.51M | 0.3% |
+51,510
| New | +$9.51M |
|
40
Viatris
VTRS
$12.3B
| $5.85M | 0.19% |
+161,930
| New | +$5.85M |
|
|
PTE
41
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $5.76M | 0.18% |
+9,783
| New | +$5.76M |
|
42
Tenet Healthcare
THC
$16.5B
| $5.29M | 0.17% |
+157,550
| New | +$5.29M |
|
|
ZSAN
43
DELISTED
Zosano Pharma Corporation
ZSAN
| $2.27M | 0.07% |
15,869
+155
| +1% | +$22.1K |
|
44
Myriad Genetics
MYGN
$633M
| $2.18M | 0.07% |
+58,335
| New | +$2.18M |
|
|
45
Agilent Technologies
A
$35.5B
| – | – |
-1,054,000
| Closed | -$70.5M |
|
|
46
AbbVie
ABBV
$374B
| – | – |
-574,070
| Closed | -$54.3M |
|
47
Acadia Pharmaceuticals
ACAD
$4.34B
| – | – |
-1,378,000
| Closed | -$31M |
|
48
Avanos Medical
AVNS
$573M
| – | – |
-627,500
| Closed | -$28.9M |
|
49
Bio-Rad Laboratories Class A
BIO
$7.8B
| – | – |
-102,940
| Closed | -$25.7M |
|
50
Cencora
COR
$57.2B
| – | – |
-424,230
| Closed | -$36.6M |
|